| Year |
Citation |
Score |
| 2012 |
Fu W, Ergun A, Lu T, Hill JA, Haxhinasto S, Fassett MS, Gazit R, Adoro S, Glimcher L, Chan S, Kastner P, Rossi D, Collins JJ, Mathis D, Benoist C. A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells. Nature Immunology. 13: 972-80. PMID 22961053 DOI: 10.1038/Ni.2420 |
0.416 |
|
| 2008 |
Haxhinasto S, Mathis D, Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. The Journal of Experimental Medicine. 205: 565-74. PMID 18283119 DOI: 10.1084/Jem.20071477 |
0.539 |
|
| 2007 |
Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, Melamed R, Mathis D, Benoist C. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity. 27: 786-800. PMID 18024188 DOI: 10.1016/J.Immuni.2007.09.010 |
0.503 |
|
| 2007 |
Haxhinasto S, Benoist C, Mathis D. Regulatory T-cell differentiation: Committed to control: a precocious choice? Immunology and Cell Biology. 85: 175-6. PMID 17310224 DOI: 10.1038/Sj.Icb.7100041 |
0.328 |
|
| 2004 |
Haxhinasto SA, Bishop GA. Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation. The Journal of Biological Chemistry. 279: 2575-82. PMID 14604983 DOI: 10.1074/Jbc.M310628200 |
0.678 |
|
| 2003 |
Bishop GA, Haxhinasto SA, Stunz LL, Hostager BS. Antigen-specific B-lymphocyte activation. Critical Reviews in Immunology. 23: 149-97. PMID 14584878 DOI: 10.1615/Critrevimmunol.V23.I3.10 |
0.531 |
|
| 2003 |
Haxhinasto SA, Bishop GA. A novel interaction between protein kinase D and TNF receptor-associated factor molecules regulates B cell receptor-CD40 synergy. Journal of Immunology (Baltimore, Md. : 1950). 171: 4655-62. PMID 14568940 DOI: 10.4049/Jimmunol.171.9.4655 |
0.672 |
|
| 2003 |
Hostager BS, Haxhinasto SA, Rowland SL, Bishop GA. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. The Journal of Biological Chemistry. 278: 45382-90. PMID 12958312 DOI: 10.1074/Jbc.M306708200 |
0.647 |
|
| 2002 |
Haxhinasto SA, Hostager BS, Bishop GA. Cutting edge: molecular mechanisms of synergy between CD40 and the B cell antigen receptor: role for TNF receptor-associated factor 2 in receptor interaction. Journal of Immunology (Baltimore, Md. : 1950). 169: 1145-9. PMID 12133933 DOI: 10.4049/Jimmunol.169.3.1145 |
0.67 |
|
| 2002 |
Stunz LL, Lenert P, Peckham D, Yi AK, Haxhinasto S, Chang M, Krieg AM, Ashman RF. Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. European Journal of Immunology. 32: 1212-22. PMID 11981808 DOI: 10.1002/1521-4141(200205)32:5<1212::Aid-Immu1212>3.0.Co;2-D |
0.372 |
|
| Show low-probability matches. |